Non-modifiable predictors comprised baseline elevated urea (OR = 1.47, 95% CI: 1.08–2.02), elevated triglycerides (TG) (cholestatic injury: OR = 1.47, 95% CI: 1.08–2.02), elevated C-reactive protein (CRP) (cholestatic injury: OR = 1.47, 95% CI: 1.08–2.02), pre-existing liver disease (liver cirrhosis, OR = 2.16, 95% CI: 1.58–2.96), diabetes (OR = 2.19, 95% CI: 1.70–2.80), and transplant status (hematopoietic stem cell transplantation, OR = 2.93, 95% CI: 1.85–4.65). This evidence concerns the gene CRP and liver disorder.